Loading...
ASCEND LABORATORIES,LLC — Cephalexin Import Profile: Suppliers, Formulations & Sources
Loading...
Pharmaceutical Importer · #2 buyer for Cephalexin · $7.3M import value · 305 shipments · UNITED STATES · DGFT Verified
ASCEND LABORATORIES,LLC is the #2 importer of Cephalexin from India with $7.3M in import value and 305 verified shipments. ASCEND LABORATORIES,LLC holds a 0.1% market share in Cephalexin imports based in UNITED STATES. The company sources from 1 verified supplier across 134 formulations shipped to 2 countries. Overall, ASCEND LABORATORIES,LLC imports 25 pharmaceutical products worth $163.5M across 12 therapeutic categories.
Verified from 305 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| ALKEM LABORATORIES LIMITED | $7.3M | 305 | 100.0% |
ASCEND LABORATORIES,LLC sources Cephalexin from 1 verified Indian supplier based on 305 customs records. The primary supplier is ALKEM LABORATORIES LIMITED accounting for 100.0% of imports.
Buyers ranked immediately above and below #2 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | ASCEND LABORATORIES,LLC ★ | UNITED STATES | $13.3M | 266 | $50.0K |
| 5 | ASCEND LABORATORIES LLC ★ | UNITED STATES | $9.5M | 190 | $50.0K |
| 6 | BREATHEFREE LANKA PVT LTD | SRI LANKA | $6.8M | 135 | $50.0K |
ASCEND LABORATORIES,LLC ranks #2 among 516 Cephalexin importers from India. Average shipment value of $50.0K compared to the market average of $86.7K. The closest competitors by value are BREATHEFREE LANKA PVT LTD.
Destination countries from 305 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $7.1M | 296 | 97.7% |
| UNITED ARAB EMIRATES | $171.0K | 9 | 2.3% |
ASCEND LABORATORIES,LLC imports Cephalexin to 2 countries. The primary destination is UNITED STATES receiving 97.7% of shipments worth $7.1M.
| Formulation | Value | Shipments |
|---|---|---|
| Pharmaceutical Products - CEPHALEXIN 500MG CAPS (500'S) ANDA | $830.5K | 19 |
| Pharmaceutical Products - CEPHALEXIN 500MG CAPS (500'S) ANDA | $446.1K | 9 |
| PHARMACEUTICAL PRODUCTS: CEPHALEXIN 500M | $200.0K | 4 |
| PHARMACEUTICAL PRODUCTS:CEPHALEXIN 500MG | $186.2K | 4 |
| PHARMACEUTICAL PRODUCTS:CEPHALEXIN 500MGCAPS (500S) ANDA NDC NO67877021905 EACH CAPSULES CONTAINS:CEPHALEXIN MONOHYDRA | $145.9K | 3 |
| PHARMACEUTICAL PRODUCTS:CEPHALEXIN 500MGCAPS (500S) ANDA NDC NO67877021905 (QTY 7783 X 500S) | $144.6K | 3 |
| Pharmaceutical Products - CEPHALEXIN 250MG CAPS (100'S)ANDA | $139.9K | 3 |
| Pharmaceutical Products - CEPHALEXIN 500MG CAPS (100'S)ANDA | $136.3K | 5 |
What ASCEND LABORATORIES,LLC and other importers must comply with to import Cephalexin from India
U.S. Food and Drug Administration (FDA)
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
India exported $44.7M worth of Cephalexin through 5,117 shipments from 223 suppliers to 104 countries, serving 516 buyers globally. ASCEND LABORATORIES,LLC imports $7.3M of this total, accounting for 0.1% of India's Cephalexin exports with 305 shipments from UNITED STATES. This is verified from 305 customs shipment records covering 134 distinct formulations.
ASCEND LABORATORIES,LLC's average Cephalexin order value is $23.9K per consignment, based on 305 shipments totaling $7.3M. ASCEND LABORATORIES,LLC is based in UNITED STATES and ranks #2 among all Cephalexin importers from India by value. The company sources from 1 verified supplier in India.
ASCEND LABORATORIES,LLC sources Cephalexin from 1 verified Indian supplier: ALKEM LABORATORIES LIMITED ($7.3M, 100.0%). This is based on 305 customs records.
ASCEND LABORATORIES,LLC ranks #2 among 516 Cephalexin importers from India with a 0.1% market share. The top 3 importers are ASCEND LABORATORIES,LLC ($13.3M), ASCEND LABORATORIES LLC ($9.5M), BREATHEFREE LANKA PVT LTD ($6.8M). ASCEND LABORATORIES,LLC processed 305 shipments from UNITED STATES.
ASCEND LABORATORIES,LLC imports 25 products worth $163.5M. Beyond Cephalexin, top products include Metformin, Amlodipine, Gabapentin, Ibuprofen, Ezetimibe. View the complete ASCEND LABORATORIES,LLC profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Cephalexin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for ASCEND LABORATORIES,LLC's Cephalexin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
ASCEND LABORATORIES,LLC
Full Company Profile →
25 products · $163.5M total trade · 12 categories
| PHARMACEUTICAL PRODUCTS:CEPHALEXIN 500MGCAPS (500'S) ANDA NDC NO67877021905,EACH CAPSULES CONTAINS:CEPHALEXIN MONOHYDRA | $127.9K | 3 |
| Pharmaceutical Products - CEPHALEXIN FOS USP 250 MG/5ML(100ML) | $126.3K | 5 |
ASCEND LABORATORIES,LLC imports 134 distinct Cephalexin formulations from India. The top formulation is Pharmaceutical Products - CEPHALEXIN 500MG CAPS (500'S) ANDA with 19 shipments worth $830.5K.
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 104+ countries, 516+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Verified from customs records
Access shipment-level records, supplier contacts, and formulation details for ASCEND LABORATORIES,LLC.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Cephalexin. For current order-level data, contact TransData Nexus.